Keys to prevent iron hijacking and infection by intracellular bacteria
Keys to prevent iron hijacking and infection by intracellular bacteria
批准号:
10089410
负责人:
YASUKO RIKIHISA
金额:
$39.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-02-01 至 2025-01-31
关键词:
Aerobic BacteriaAmino AcidsAnimal DiseasesAutophagocytosisAutophagosomeBackBacteriaBindingCellsCommunicable DiseasesComplementary DNACytoplasmDeferoxamineDevelopmentDoxycyclineEhrlichiaEhrlichia chaffeensisEhrlichiosisEmerging Communicable DiseasesFerritinFutureGoalsGrowthHomeostasisHost Defense MechanismHumanHybridsImmunologicsInfectionInterventionIronIron Chelating AgentsIron Superoxide DismutaseKineticsKnock-inKnowledgeLeukocytesLibrariesLightLinkMapsMediatingMembraneMetabolismMissionMitochondriaMolecularNuclear Receptor Coactivator 4OrganellesOxidesPathogenesisPatternPeptide Nucleic AcidsPharmacologyPrevalencePreventive measureProcessProteinsPublic HealthReactive Oxygen SpeciesRickettsiaRiskRoleSOD2 geneSignal PathwaySmall Interfering RNASuperoxidesSurfaceSurface Plasmon ResonanceTestingTherapeuticTicksTimeTissuesTransfectionType IV Secretion System PathwayUnited States National Institutes of HealthWorkYeastsbasecell injurydisabilityhuman diseaseinnovationiron metabolismknock-downmacrophagemonocytemutantnanobodiesnovelnovel strategiespathogenpreventresponsescreeningtick-borne
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The gram-negative obligatory intracellular bacterium Ehrlichia chaffeensis (Ech) infects monocytes-
macrophages, and causes the emerging tick-borne zoonosis human monocytic ehrlichiosis (HME). Our long-
term goal is to identify targets for intervention that can prevent and treat HME. As an obligatory intracellular
aerobe, Ech is dependent upon host iron for survival. We found that pretreating human macrophages with the
iron chelator deferoxamine resulted in a complete block of Ech infection, suggesting Ech acquires iron from the
host labile cellular iron (LCI) pool. Paradoxically, the host LCI pool catalyzes formation of reactive oxygen
species (ROS), which is a key mechanism of host defense against intracellular pathogens. Our project's
objective is to determine the mechanism by which Ech modulates the host LCI pool to acquire iron for its
growth, while averting ROS-induced host cell response. By understanding the process by which Ech acquires
iron, we may be able to prevent or limit infection. We previously found functional links between Type IV
Secretion System (T4SS, VirB/D), iron, and superoxide dismutatses of Ech and host cells.
Ferritin contains
heavy chain (FTH) and light chain (FTL) subunits; in our preliminary study we found that the T4SS effector,
Ehrlichia translocated factor (Etf)-3
interacts directly with FTL, and colocalizes with LC3 (ATG8), a maker of
autophagosomes. Thus, o
ur central hypothesis is that Ech induces ferritinophagy, a form of selective
autophagy that degrades ferritin and increases the LCI pool by secreting Etf-3, and safely captures iron. We
will test our central hypothesis with three Specific Aims: Aim 1. Analyze the interaction between Etf-3 and FTL:
Etf-3 binding kinetics to human native ferritin; temporal pattern of Etf-3-FTL binding during the course of Ech
infection; Etf-3 binding to other molecules in Ech-infected and uninfected cells, including nuclear receptor
coactivator 4 (NCOA4); and cellular co-localization of Etf-3 and ferritin. Aim 2. Determine if Ech induces
ferritinophagy that coincides with lowering ROS via T4SS, and if Etf-3-induced ferritinophagy is required for
productive Ech infection; determine the roles of FTL, FTH, and NCOA4 in Ech infection; compare Etf-3-induced
ferritinophagy to Etf-1-induced Rab5-regulated autophagy; determine if NCOA4 mediates Etf-3-induced
ferritinophagy; and map the Etf-3 domains/segments that induce ferritinophagy. Aim 3. Determine if blocking
Etf-3 expression and binding to FTL inhibits Ech-induced ferritinophagy and Ech infection. Elucidating how
intracellular Ech acquires iron will 1) further our understanding of intracellular bacterial proliferation and
survival, and 2) reveal the role of iron homeostasis that may be a critical target for development of new
approaches to prevent or limit Ech infection. If our hypothesis is supported, the results will also reveal a unique
molecular mechanism of ferritinophagy that may be inhibited, benefiting the broader fields of infectious
diseases and iron homeostasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted Prevention of Human Ehrlichiosis
-
批准号:10755407
-
项目类别:
-
资助金额:$2.31万
-
财政年份:2021
-
负责人:YASUKO RIKIHISA
-
依托单位:
Targeted Prevention of Human Ehrlichiosis
-
批准号:10470709
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:YASUKO RIKIHISA
-
依托单位:
Targeted Prevention of Human Ehrlichiosis
-
批准号:10667509
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:YASUKO RIKIHISA
-
依托单位:
Targeted Prevention of Human Ehrlichiosis
-
批准号:9990077
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:YASUKO RIKIHISA
-
依托单位:
Keys to prevent iron hijacking and infection by intracellular bacteria
-
批准号:10552677
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:YASUKO RIKIHISA
-
依托单位:
Keys to prevent iron hijacking and infection by intracellular bacteria
-
批准号:10330564
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:YASUKO RIKIHISA
-
依托单位:
Inhibition of Ehrlichial Infection by Intracellular Nanobody
-
批准号:9808090
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:YASUKO RIKIHISA
-
依托单位:
Keys to prevent cholesterol robbery and infection by intracellular bacteria
-
批准号:8415504
-
项目类别:
-
资助金额:$35.84万
-
财政年份:2012
-
负责人:YASUKO RIKIHISA
-
依托单位:
Keys to prevent cholesterol robbery and infection by intracellular bacteria
-
批准号:8270716
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2012
-
负责人:YASUKO RIKIHISA
-
依托单位:
Comparison of Human Ehrlichiosis Agent Genomes
-
批准号:7911775
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2007
-
负责人:YASUKO RIKIHISA
-
依托单位:
Comparison of Human Ehrlichiosis Agent Genomes
-
批准号:7676884
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2007
-
负责人:YASUKO RIKIHISA
-
依托单位:
Comparison of Human Ehrlichiosis Agent Genomes
-
批准号:7492067
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2007
-
负责人:YASUKO RIKIHISA
-
依托单位:
Comparison of Human Ehrlichiosis Agent Genomes
-
批准号:7317213
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2007
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:7326790
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:8206462
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:6836028
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:6731296
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:8415832
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:7010048
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
-
批准号:7577126
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:YASUKO RIKIHISA
-
依托单位:
海外基金